5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management

2. Krystal Biotech, Inc. (NASDAQ:KRYS)

Point72 Asset Management’s Holdings: $129 million

Percentage of Point72 Asset Management’s Portfolio: 0.51%

Number of Hedge Fund Holders: 14

Krystal Biotech, Inc. (NASDAQ:KRYS) is a gene therapy provider headquartered in Pittsburg, Pennsylvania. The company’s products target several kinds of skin diseases, such as rare kinds of blisters, skin colored scales, and other rare but serious disorders.

By the end of the fourth quarter of last year, Mr. Cohen’s investment firm owned 1.8 million Krystal Biotech, Inc. (NASDAQ:KRYS) shares which were worth $129 million and represented 0.51% of its 13F investment portfolio. Insider Monkey scanned the portfolios of 924 13F-filing hedge funds in our database and found that 14 were investors of the firm. Jeremy Green’s Redmile Group is one of Krystal Biotech, Inc. (NASDAQ:KRYS)’s largest investors, owning 1.8 million shares that represent a $127 million stake as of December 31.

Krystal Biotech, Inc. (NASDAQ:KRYS) posted a loss of $3.13 in GAAP EPS for its fiscal fourth quarter, significantly missing analyst estimates. However, during the same time period, the company also significantly grew its cash and other investments, which stood at $502.5 million. These reflected the proceeds from the public offerings of its shares.